BOOSTRIX
BOOSTRIX
Approved
DIN Number
02247600
Drug Class
Human
Market Date
May 29, 2007
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02247600
AIG Number0533121002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AX OTHER BACTERIAL VACCINES
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:08.00
Health Canada Classification
ACTIVE INGREDIENTS (5)
DIPHTHERIA TOXOIDActive
Strength: 2 UNIT / 0.5 ML
Monograph: DIPHTHERIA TOXOID
FILAMENTOUS HAEMAGGLUTININActive
Strength: 8 MCG / 0.5 ML
Monograph: FILAMENTOUS HAEMAGGLUTININ
PERTACTINActive
Strength: 2.5 MCG / 0.5 ML
Monograph: PERTACTIN
PERTUSSIS TOXOIDActive
Strength: 8 MCG / 0.5 ML
Monograph: PERTUSSIS TOXOID
TETANUS TOXOIDActive
Strength: 20 UNIT / 0.5 ML
Monograph: TETANUS TOXOID